Enterprise Business Models

Momentum for electronic clinical trials is increasing worldwide and the availability of unified information platforms that provide the convenience of single-source contracting will create new and more efficient business model options in 2007 and beyond...

Measure To Manage

Just Because We Measured It, Doesn't Mean We Changed!.

Using EDC to Improve Monitoring Practices Worldwide

The benefits of EDC are widely reported, but little is known about how it can be used in global studies in terms of assessing monitoring practices or standardizing operations. This case study attempted to use standard reports to help track and improve monitoring practices.

Additionally, this article is published in the SCDM Data Basics magazine Winter 2004 issue.

Read More

Dr. Jeffrey Green wins Ernst & Young "2004 Entrepreneur of the Year Award"

Tracking results. DATATRAK is moving the pharmaceutical industry into the modern age.

Read More

Benefits of eCRF and EDC vs. Paper

Does Your EDC Product Complete its Case Report Form in Pencil?
Some analysts predict a 14% EDC adoption rate in clinical trials by 2003 and a 24% rate by 2004 across the global market. To avoid regulatory risk to the Sponsor and to increase the speed and efficiency of the upgrade, the transition to EDC should be guided by an informed scrutiny of all the available technology platforms and products and a careful comparison of EDC with paper workflows.

Read More

EDC Value Proposition Part II

Detailed Costs Comparison of EDC Versus Paper Model for Nineteen (19) Clinical Research Projects (Phase I – IIIb)
Includes an Assessment of Workflow Transitions from Conventional to EDC Processes.

• Projected cost savings are expected to exceed $60 Million for an average successful Clinical Development Program.


• Implementation of an Enterprise EDC solution produces substantial operational cost savings compared to traditional paper methods.

EDC and Patient Safety in Clinical Trials

By augmenting "data awareness", technology can improve the ability to react to information in clinical trials for the betterment of patients.

Read More

Company

• Overview
• About Us
• Letter From The CEO
• Events
• Investor Relations
• Press Releases
• Publications
• Management Team
• Careers